Servier’s brain tumour treatment approved by US FDA
Servier Pharmaceuticals said the US FDA approved its treatment for a type of brain tumour, becoming the first drug to gain approval in the US for the disease. The drug, known as voranigo, is used to treat a form of brain cancer, called IDH-mutated grade 2 glioma, in patients who have undergone surgery.
POPULAR POSTS
Portugal declares risk as wildfires hit the north of the country
September 17, 2024
UK to appoint nature envoy
September 17, 2024
Death tolls rises as Central Europe floods
September 17, 2024
LIVE STREAM